1. Long-term safety of photobiomodulation exposure to beta cell line and rat islets in vitro and in vivo
- Author
-
Quentin Perrier, Cécile Cottet-Rousselle, Fréderic Lamarche, Emily Tubbs, Cindy Tellier, Jade Veyrat, Guillaume Vial, Pierre Bleuet, Aude Durand, Amandine Pitaval, Marie-Line Cosnier, Cécile Moro, and Sandrine Lablanche
- Subjects
Diabetes ,Photobiomodulation ,Beta cells ,Insulinosecretion ,Viability ,Functionnality ,Medicine ,Science - Abstract
Abstract This study evaluates the safety and potential benefits of PBM on pancreatic beta cells and islets. PBM was applied to insulin-secreting cell lines (MIN6) and rat pancreatic islets using a 670 nm light source, continuous output, with a power density of 2.8 mW/cm², from 5 s to several 24 h. Measure of cell viability, insulin secretion, mitochondrial function, ATP content, and cellular respiration were assessed. Additionally, a diabetic rat model is used for islet transplantation (pre-conditioning with PBM or not) experiments. Short and long-term PBM exposure did not affect beta cell islets viability, insulin secretion nor ATP content. While short-term PBM (2 h) increases superoxide ion content, this was not observed for long exposure (24 h). Mitochondrial respirations were slightly decreased after PBM. In the islet transplantation model, both pre-illuminated and non-illuminated islets improved metabolic control in diabetic rats with a safety profile regarding the post-transplantation period. In summary, for the first time, long-term PBM exhibited safety in terms of cell viability, insulin secretion, energetic profiles in vitro, and post-transplantation period in vivo. Further investigation is warranted to explore PBM’s protective effects under conditions of stress, aiding in the development of innovative approaches for cellular therapy.
- Published
- 2024
- Full Text
- View/download PDF